Literature DB >> 4019539

Giant-cell tumor of bone with pulmonary metastases.

F Bertoni, D Present, W F Enneking.   

Abstract

We reviewed the cases of seven patients with histologically benign primary giant-cell tumor of bone and histologically proved metastases to the lung. All seven had a Stage-3, aggressive, benign lesion with interruption of the cortex and soft-tissue extension. The main histological features of the primary lesion were identical to those of the pulmonary metastases. In only one of the seven patients were the metastases detected simultaneously with the primary lesion. All seven patients were treated by surgical resection of the lung nodules and chemotherapy. Of the seven patients, four were alive and free of disease after an average follow-up of nine years; two were receiving chemotherapy; and one, who had had immunosuppression for an allograft transplant, died less than one year after the discovery of the pulmonary lesions. Based on this small series, we concluded that patients with a Stage-3 giant-cell tumor of bone may be at risk for pulmonary spread of the disease. This lesion, with its benign histological picture even in lung lesions, has a favorable prognosis when treated with pulmonary resection of the nodules. However, the role for chemotherapy after pulmonary surgery is still unclear.

Entities:  

Mesh:

Year:  1985        PMID: 4019539

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  30 in total

1.  Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.

Authors:  M Alberghini; K Kliskey; T Krenacs; P Picci; L Kindblom; R Forsyth; N A Athanasou
Journal:  Virchows Arch       Date:  2009-12-15       Impact factor: 4.064

2.  Chest X-ray mass.

Authors:  P Sundaram; J M Joseph; B Trivedi; L P Naik; J M Joshi
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

3.  Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.

Authors:  Joo Han Oh; Pil Whan Yoon; Sang Hoon Lee; Hwan Seong Cho; Woo Sung Kim; Han-Soo Kim
Journal:  Int Orthop       Date:  2006-05-31       Impact factor: 3.075

4.  Clival giant cell tumor presenting with isolated trigeminal nerve involvement.

Authors:  Soumyajit Roy; Nikhil P Joshi; Elanthenral Sigamani; Anita Malik; Meher C Sharma; Bidhu K Mohanti; Suresh C Sharma
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-10       Impact factor: 2.503

Review 5.  Giant-cell tumours of bone of the hand and wrist: a review of imaging findings and differential diagnoses.

Authors:  S L J James; A M Davies
Journal:  Eur Radiol       Date:  2005-05-03       Impact factor: 5.315

6.  Giant cell tumor of bone: are we stratifying results appropriately?

Authors:  Thomas J Kremen; Nicholas M Bernthal; Mark A Eckardt; Jeffrey J Eckardt
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

7.  Metachronous multicentric giant-cell tumor of the bone in the lower limb. Case report and Ki-67 immunohistochemistry study.

Authors:  Marc-Antoine Rousseau; Adriana Handra-Luca; Jean-Yves Lazennec; Yves Catonné; Gérard Saillant
Journal:  Virchows Arch       Date:  2004-05-11       Impact factor: 4.064

8.  [Giant cell tumor of bone with rapid malignant course].

Authors:  M R Lachat; M Weber; M D Cserhati; H P Honegger; A R von Hochstetter
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

9.  What role for radiobiphosphonates bone scintigraphy in the monitoring of an unusual bone giant cell tumor: a case report and literature review.

Authors:  Salah Nabih Oueriagli; Imad Ghfir; Hassna El Guerrouj; Nouzha Ben Raïs
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-04-24

10.  Recurrent pulmonary metastases from benign giant cell tumors of the bone: report of two cases and analysis of nuclear DNA content by flow cytometry.

Authors:  I Takanami; T Imamura; N Morota; S Kodaira
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.